Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Submitted by
admin
on September 19, 2018 - 11:27am
Source:
CP Wire
News Tags:
Exelixis
Cabometyx
Takeda
Canada
Japan
Ipsen
renal cell carcinoma
Headline:
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
snippet:
Cabometyx has orphan drug status in the US
Takeda has rights to all indications for Cabometyx in Japan
Do Not Allow Advertisers to Use My Personal information
